These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2744077)

  • 1. Characterization of the antimuscarinic effect of heptane-1,7-bis-(dimethyl-3'-phthalimidopropyl ammonium bromide).
    Choo LK; Mitchelson F
    Eur J Pharmacol; 1989 Mar; 162(3):429-35. PubMed ID: 2744077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the allosteric interactions of the bisquaternary heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at M1 and M2 muscarine receptors.
    Christopoulos A; Mitchelson F
    Mol Pharmacol; 1994 Jul; 46(1):105-14. PubMed ID: 8058045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of the muscarine receptor antagonist heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at cholinoceptor sites.
    Christopoulos A; Loiacono R; Mitchelson F
    Eur J Pharmacol; 1993 Jun; 246(1):1-8. PubMed ID: 8354340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimuscarinic action of an alkane-bis-ammonium compound alone and in combination with (+)-benzetimide.
    Mitchelson F
    Eur J Pharmacol; 1975; 33(2):237-46. PubMed ID: 1242377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the muscarine receptor subtype on sympathetic nerve endings in the rat caudal artery.
    Shen A; Mitchelson F
    Eur J Pharmacol; 1994 Feb; 252(2):167-72. PubMed ID: 7512503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding studies on two functional cardioselective antimuscarinic compounds.
    Choo LK; Mitchelson F
    J Pharm Pharmacol; 1988 Apr; 40(4):288-9. PubMed ID: 2900313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site.
    Tränkle C; Andresen I; Lambrecht G; Mohr K
    Mol Pharmacol; 1998 Feb; 53(2):304-12. PubMed ID: 9463489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of agonists with an allosteric antagonist at muscarinic acetylcholine M2 receptors.
    Lanzafame A; Christopoulos A; Mitchelson F
    Eur J Pharmacol; 1996 Nov; 316(1):27-32. PubMed ID: 8982646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a spreadsheet to quantitate the equilibrium binding of an allosteric modulator.
    Christopoulos A; Mitchelson F
    Eur J Pharmacol; 1998 Aug; 355(1):103-11. PubMed ID: 9754944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric stabilization of 3H-N-methylscopolamine binding in guinea-pig myocardium by an antidote against organophosphate intoxication.
    Jepsen K; Lüllmann H; Mohr K; Pfeffer J
    Pharmacol Toxicol; 1988 Sep; 63(3):163-8. PubMed ID: 3054859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Displacement of [3H]oxotremorine-M binding by muscarinic antagonists in guinea-pig atrial and ileal membrane homogenates.
    Choo LK; Mitchelson F
    Eur J Pharmacol; 1988 Jul; 151(2):197-204. PubMed ID: 3169122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation by alcuronium of the antimuscarinic effect of N-methylscopolamine in guinea pig left atria.
    Maass A; Kostenis E; Mohr K
    Eur J Pharmacol; 1995 Jan; 272(1):103-6. PubMed ID: 7713140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic receptor binding in the guinea pig urinary bladder.
    Nilvebrant L; Sparf B
    Acta Pharmacol Toxicol (Copenh); 1983 Jan; 52(1):30-8. PubMed ID: 6837322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of gallamine and pancuronium to inhibit selectively (-)-[3H]quinuclidinyl benzilate binding in guinea-pig atria.
    Choo LK; Leung E; Mitchelson F
    Can J Physiol Pharmacol; 1985 Mar; 63(3):200-8. PubMed ID: 3838695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the neuromuscular blocking drug atracurium with muscarinic acetylcholine receptors.
    Musílková J; Starshinova LA; Shelkovnikov SA; Tucek S
    Physiol Res; 1991; 40(3):293-304. PubMed ID: 1751476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimuscarinic action of methoctramine, a new cardioselective M-2 muscarinic receptor antagonist, alone and in combination with atropine and gallamine.
    Melchiorre C; Angeli P; Lambrecht G; Mutschler E; Picchio MT; Wess J
    Eur J Pharmacol; 1987 Dec; 144(2):117-24. PubMed ID: 3436364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors.
    Lanzafame A; Christopoulos A; Mitchelson F
    J Pharmacol Exp Ther; 1997 Jul; 282(1):278-85. PubMed ID: 9223565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective antimuscarinic action of stercuronium.
    Li CK; Mitchelson F
    Br J Pharmacol; 1980 Oct; 70(2):313-21. PubMed ID: 6893558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic studies of co-operativity at atrial muscarinic M2 receptors with an "infinite dilution" procedure.
    Christopoulos A; Lanzafame A; Ziegler A; Mitchelson F
    Biochem Pharmacol; 1997 Mar; 53(6):795-800. PubMed ID: 9113100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the antimuscarinic and other actions of proadifen in-vitro.
    Choo LK; Malta E; Mitchelson F
    J Pharm Pharmacol; 1986 Dec; 38(12):898-901. PubMed ID: 2880963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.